KLISBio Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 21

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $15.7M

  • Investors
  • 13

KLISBio General Information

Description

Developer of an innovative medical technology designed to find new tissue regeneration methods. The company's technology offers silk-based bio-materials that help to regenerate human tissues, including those present in the vascular system, and then to degrade and be safely absorbed in the body, enabling medical research companies to develop products harnessing the power of nano-fibers and use them for the treatment of tissue-related diseases.

Contact Information

Website
www.klis.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Via Ludovico Ariosto, 21
  • Bresso
  • 20091 Milan
  • Italy
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Via Ludovico Ariosto, 21
  • Bresso
  • 20091 Milan
  • Italy

KLISBio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

KLISBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 01-Jan-2025 $15.7M Completed Generating Revenue
8. Grant 08-Nov-2023 Completed Startup
7. Later Stage VC 31-Dec-2022 Completed Startup
6. Early Stage VC (Series A) 21-Apr-2016 Completed Startup
5. Seed Round 11-Dec-2015 Completed Startup
4. Accelerator/Incubator Completed Startup
3. Grant 05-Aug-2015 Completed Startup
2. Grant 05-Dec-2014 $31.1K Completed Startup
1. Accelerator/Incubator Completed Startup
To view KLISBio’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

KLISBio Patents

KLISBio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3227954-A1 Biomimetic peptides and their use in bone regeneration Pending 09-Aug-2021
US-20250129123-A1 Biomimetic peptides and their use in bone regeneration Pending 09-Aug-2021
WO-2023016904-A1 Biomimetic peptides and their use in bone regeneration Inactive 09-Aug-2021
AU-2018248085-A1 Nanofibers comprising fibroin as well as system comprising hydrogel and said nanofibers Inactive 04-Apr-2017
EP-3607117-A1 Nanofibers comprising fibroin as well as system comprising hydrogel and said nanofibers Inactive 04-Apr-2017 D01D5/003
To view KLISBio’s complete patent history, request access »

KLISBio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

KLISBio Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
CDP Venture Capital (Rome) Venture Capital Minority
Primo Capital (Milano) Venture Capital Minority
Tech and Biomedical Foundation Venture Capital Minority
European Innovation Council Accelerator/Incubator Minority
Anya Capital Venture Capital Minority
You’re viewing 5 of 13 investors. Get the full list »

KLISBio FAQs

  • When was KLISBio founded?

    KLISBio was founded in 2014.

  • Where is KLISBio headquartered?

    KLISBio is headquartered in Milan, Italy.

  • What is the size of KLISBio?

    KLISBio has 21 total employees.

  • What industry is KLISBio in?

    KLISBio’s primary industry is Therapeutic Devices.

  • Is KLISBio a private or public company?

    KLISBio is a Private company.

  • What is KLISBio’s current revenue?

    The current revenue for KLISBio is .

  • How much funding has KLISBio raised over time?

    KLISBio has raised $27.3M.

  • Who are KLISBio’s investors?

    CDP Venture Capital (Rome), Primo Capital (Milano), Tech and Biomedical Foundation, European Innovation Council, and Anya Capital are 5 of 13 investors who have invested in KLISBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process